Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 1 chart position in 1 market.
By chart position
- 🇺🇸US · Medicine#1985K to 30K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
2.5K to 15K🎙 ~2x weekly·40 episodes·Last published 5d ago - Monthly Reach
Unique listeners across all episodes (30 days)
5K to 30K🇺🇸100% - Active Followers
Loyal subscribers who consistently listen
2K to 12K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
S7E7: National Lipid Day Special: The Lipid Doctor’s Truths Every Clinician Should Know
May 10, 2026
57m 52s
S7E6: Identification of Rare Lipid Disorders in Children
Apr 16, 2026
27m 58s
S7E5: Tackling Childhood Obesity: Innovative Strategies for a Healthier Future
Apr 3, 2026
26m 59s
S7E4: 2026 ACC/AHA Cholesterol (Dyslipidemia) Guidelines: Clinical Meaning for Lipidologists
Mar 17, 2026
41m 47s
S7E3: LDL-C Reduction in Primary Prevention: Insights from a New Meta-Analysis
Mar 5, 2026
21m 39s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 5/10/26 | S7E7: National Lipid Day Special: The Lipid Doctor’s Truths Every Clinician Should Know | What does your patient's lipid panel actually tell you and what is it missing? In this special National Lipid Day episode of Lipid Insights, host Peter H. Jones, MD, MNLA, sits down with Thomas Dayspring, MD, FACP, MNLA — widely known as "The Lipid Doctor" — for a conversation that challenges some of medicine's most entrenched assumptions about lipid risk assessment. From the clinical superiority of ApoB over LDL-C and the underrecognized atherogenic burden of Lipoprotein(a), to why HDL-C sho... | 57m 52s | ||||||
| 4/16/26 | S7E6: Identification of Rare Lipid Disorders in Children | In this episode of Lipid Insights, host Peter H. Jones, MD, MNLA sits down with Nivedita Patni, MD, of the Department of Pediatrics at UT Southwestern Medical Center in Dallas, TX, to explore the complex landscape of pediatric dyslipidemia. Dr. Patni walks through the critical importance of tailoring management to etiology, the long-term cardiovascular and metabolic risks that hang in the balance, and why early identification is everything. Drawing on case studies and evidence-based manageme... | 27m 58s | ||||||
| 4/3/26 | S7E5: Tackling Childhood Obesity: Innovative Strategies for a Healthier Future | Childhood obesity is one of the most pressing public health challenges of our time — and its long-term cardiovascular and metabolic consequences make it essential territory for lipidologists and clinicians alike. In this episode of Lipid Insights, host Peter H. Jones, MD, MNLA sits down with Casey Berman, MD to explore the full picture: how childhood obesity is defined, why its prevalence continues to rise, and the behavioral, societal, and genetic factors fueling the epidemic. They also div... | 26m 59s | ||||||
| 3/17/26 | S7E4: 2026 ACC/AHA Cholesterol (Dyslipidemia) Guidelines: Clinical Meaning for Lipidologists | Join host Dr. Peter H. Jones for a special episode of Lipid Insights discussing the 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia. Dr. Jones is joined by guideline author and NLA Past President Dr. Joseph Saseen and NLA President-Elect Dr. Dinesh Kalra to break down what clinicians need to know. From the restoration of LDL-C treatment goals and major conceptual shifts from the 2018 guideline, to primordial and primary prevention, risk assessment, special populations, a... | 41m 47s | ||||||
| 3/5/26 | S7E3: LDL-C Reduction in Primary Prevention: Insights from a New Meta-Analysis | In this episode of Lipid Insights, we explore the NLA's recent expert meta-analysis, "Low-density lipoprotein cholesterol lowering and risk of major adverse cardiovascular events in primary prevention trials." Lead author Dinesh K. Kalra, MD, MBA and key author Kevin C. Maki, PhD, CLS, MNLA join host Alan S. Brown, MD, MHA, MNLA to examine the relationship between LDL-C reduction and major adverse cardiovascular events in primary prevention trials. Together, they break down the finding... | 21m 39s | ||||||
| 2/19/26 | S7E2: Addressing Obesity and Weight Loss Challenges: Implications for Cardiometabolic Health | In this episode of Lipid Insights, host Dr. Peter Jones is joined by renowned experts Robert H. Eckel, MD, FNLA and Samuel M. Kim, MD for a thoughtful discussion on the complex relationship between obesity, weight loss, and cardiometabolic health. | 25m 01s | ||||||
| 1/29/26 | S7 E1: Changing the FH Playbook: Diagnosis and Treatment Updates from the NLA | Hosted by Dave Dixon, PharmD, CLS, FNLA, this episode features an in-depth discussion with three key authors of the NLA’s new statement providing updated guidance on diagnosis, management, and treatment of FH. Together, they review the most important updates in the new guidance, including recommendations for earlier identification, the role of genetic testing and cascade screening, updated LDL-cholesterol treatment targets, and the integration of newer lipid-lowering therapies. The conversati... | 1h 00m 06s | ||||||
| 12/17/25 | S6E13: The Next Era of Prevention: Rethinking Cardiovascular Health from the Ground Up | Dr. Peter Jones welcomes Dr. Nihar Desai for a forward-looking discussion on the future of cardiovascular prevention. From implementation science to performance measurement, this episode challenges traditional approaches and explores how innovation, systems thinking, and accountability can reshape how we achieve lasting cardiovascular health. Guest: Nihar R. Desai, MD, MPH Associate Professor of Medicine Yale School of Medicine Vice Chief, Section of Cardiovascular Medicine Yale New Haven H... | 13m 16s | ||||||
| 12/4/25 | S6E12: ATTAIN in Practice: Translating Data Into Lipid Decisions | In this episode of Lipid Insights, host Dr. Peter Jones is joined by Dr. Harold Bays for a practical, clinician-focused discussion of the ATTAIN Study and what it means for everyday lipid management. Together, they walk through the key questions clinicians ask when new evidence emerges: what the study set out to evaluate, how to interpret the findings in context, and where the results may (or may not) shift decision-making at the point of care. Dr. Bays brings a real-world lens to the conve... | 32m 50s | ||||||
| 11/14/25 | S6E11: Managing Lipids and Metabolic Syndrome in Youth: Tips from the Experts | Join host Peter Jones, MD, MNLA for a conversation on the evolving landscape of metabolic health in youth. In this episode, Dr. Jones is joined by two leading pediatric experts—Don Wilson, MD, FNLA and Amy Shah, MD, FNLA—to explore practical strategies and emerging research on managing lipids and metabolic syndrome in younger populations. The discussion highlights key findings from their recently published special issue in the Journal of Clinical Lipidology, offering listeners evidence-based ... | 33m 50s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 10/29/25 | S6E10: Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease | Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease Hosted by Dr. Underberg, the Rewriting the Risk Equation: The Expanding Role of Lp(a) in Atherosclerotic Disease podcast is designed to equip clinicians with the latest evidence on Lp(a) biology, screening strategies, and current and emerging therapeutic options. Along with Drs. Soffer, Kulkarni and Wilkinson, they will explore the integration of Lp(a) assessment into routine practice, implications for high-ri... | 1h 13m 05s | ||||||
| 9/25/25 | S6 Lipid Snippet: Polygenic Risk Score for Coronary Artery Disease Predicts ASCVD in FH | Can genetic scores unlock better outcomes for patients with FH? This special Snippet from our Lipid Insights podcast series dives into the award-winning abstract from #NLASessions 2025, exploring how polygenic risk scores for coronary artery disease may transform ASCVD prediction and management. Tune in and see what’s next in lipid science. Guest Host Daniel E. Soffer, MD, MNLA University of Pennsylvania Health System Internal Medicine/Clinical Lipidology Perelman Center for Advanced Medicin... | 9m 31s | ||||||
| 9/17/25 | S6E9:Beef and Cardiovascular Disease: What the Science Says | In this episode of Lipid Insights, Dr. Peter Jones and guest Dr. Kevin Maki explore whether beef deserves its long-standing reputation as a driver of cardiovascular disease. Drawing on a recent systematic review and meta-analysis, they examine beef’s impact on cholesterol, blood pressure, and other key CVD risk factors—providing fresh perspective for clinicians navigating dietary guidance. This podcast has been approved for AMA PRA Category 1 Credit™. This activity is eligible for ACPE, ANCC,... | 39m 25s | ||||||
| 9/12/25 | S6 Lipid Snippet: Universal Lipoprotein(a) Screening of Youth and Reverse Cascade Screening at a Primary Care Clinic | In this short episode, guest host Dr. Dan Soffer chats with Dr. Joshua Hyman, the Young Investigator Award winner at #NLASessions 2025. Dr. Hyman gives a quick overview of his award-winning abstract and shares insights from his work in advancing lipid research. | 11m 13s | ||||||
| 9/4/25 | S6E8: The Long Game with LDL: Lower, Longer, Better | Hosted by Dr. Dan Soffer, this conversation brings NLA President Dr. Willard and Beth Jackson together to unpack the Association’s guidance, “LDL Cholesterol Management Simplified in Adults – Lower for Longer is Better.” The trio turns a big message into practical moves: why lifetime LDL exposure matters, who needs more aggressive targets, and how to streamline therapy choices from high-intensity statins to add-ons (ezetimibe, PCSK9-directed options) when goals aren’t met. They share real-wor... | 36m 32s | ||||||
| 8/20/25 | S6E7: Next-Gen Lipid-Lowering Strategies: ANGPTL4 Inhibitor Clinical Insights | In this episode, Alan Brown, MD, MHA, MNLA sits down with Rebecca Juliano, PhD, MPhil, MA to discuss a first-in-human study of an investigational ANGPTL4 inhibitory antibody. The conversation explores how this novel therapeutic approach safely and effectively reduces plasma triglycerides and remnant cholesterol—key drivers of residual cardiovascular risk. Listeners will gain insight into the mechanism of action, clinical significance, and potential role of ANGPTL4 inhibition in the evolving l... | 20m 53s | ||||||
| 8/7/25 | S6E6: All Hands on Deck: The Power of Multidisciplinary Lipid Care | Explore the NLA’s new guidance on building effective, team-based approaches to improve outcomes in clinical lipidology and cardiometabolic care. Read the Expert Clinical Review HERE View this Episode on YouTube HERE Guest Host Daniel E. Soffer, MD, MNLA University of Pennsylvania Health System Internal Medicine/Clinical Lipidology Perelman Center for Advanced Medicine Philadelphia, PA Guests Mary Katherine Cheeley, PharmD, CLS, FNLA Executive Director, Ambulatory Pharmacy Services Grady Hea... | 40m 29s | ||||||
| 7/23/25 | S6E5: Recognition and Management of Persistent Chylomicronemia | Dive into the complexities of Persistent Chylomicronemia with this special episode recorded live at the recent National Lipid Association Scientific Sessions. Guest host Christie Ballantyne, MD, is joined by leading experts Seyedmohammad Saadatagah, MD, Erin Michos, MD, and Daniel Gaudet, MD, PhD, to break down key takeaways from the newly released Joint Expert Clinical Consensus from the National Lipid Association and the American Society for Preventive Cardiology: Recognition and Management... | 44m 28s | ||||||
| 4/7/25 | S6E4: Familial Chylomicronemia Syndrome An Expert Clinical Review from the National Lipid Association | No description provided. | 51m 49s | ||||||
| 3/25/25 | S6E3: Diets and Supplements | No description provided. | 34m 32s | ||||||
| 2/28/25 | S6E2: From Research to Reality: Advancing FCS Therapy | No description provided. | 30m 22s | ||||||
| 1/30/25 | S6E1: The role of nutrition-related clinical trials in informing dietary recommendations for health and treatment of diseases | No description provided. | 35m 12s | ||||||
| 10/9/24 | S5E5: Managing Hypercholesterolemia in Adults Aged 75 Years & Older w/o a History of ASCVD: A Scientific Statement from the NLA & AGS | No description provided. | 33m 24s | ||||||
| 10/9/24 | S5E4: Role of apolipoprotein B in the Clinical Management of Cardiovascular Risk in Adults | No description provided. | 37m 21s | ||||||
| 10/4/24 | S5E3: What’s next for Lipoprotein(a)? Insights from an Expert Discussion Group | No description provided. | 39m 56s | ||||||
Showing 25 of 42
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
1 placement across 1 market.
Chart Positions
1 placement across 1 market.